May 16th 2024
Insights from virologist Erin Sorrell PhD MSc offer perspectives on prevention and response strategies.
Baloxavir Shows Broad Antiviral Activity Against Influenza A, B, C, and D
July 24th 2019In the wake of prior findings that influenza A viruses exhibited reduced susceptibility to single-dose baloxavir, a new study indicates that the antiviral medication inhibits all 4 types of flu, including viruses with pandemic potential.
Read More
Oseltamivir Pre-Exposure Prophylaxis Does Not Cut Influenza Rates in Lung Transplant Recipients
May 10th 2019A team of investigators from the University of North Carolina Medical Center found that oseltamivir prophylaxis did not reduce the rate of influenza within the first year following a lung transplant.
Read More
Cloudbreak Antiviral Conjugate Demonstrates Potent In Vitro Activity
April 16th 2019Cidara Therapeutics has developed CB-012, a stable conjugate of a highly potent antiviral agent linked to human IgG1 Fc, and investigators are evaluating the asset for the treatment and prevention of seasonal and pandemic influenza A and B infections.
Read More
Flu Shot, Nasal Spray Recommended Equally for Kids for 2019-2020 Season
April 2nd 2019The American Academy of Pediatrics is giving its recommendation to the nasal spray form of the influenza vaccine for the 2019-2020 flu season, meaning parents will have 2 choices when getting their children vaccinated this fall.
Read More